The Neuromodulation market in Asia Pacific is expected to grow from US$ 1,559.89 million in 2019 to US$ 3,518.34 million by 2027. This represents a CAGR of 11.0% from 2020 to 2027.
The growth of the market in the region is expected to grow owing to increasing incidence of neurological disorders, growing developments in neuromodulation technology are projected to drive the Asia Pacific neuromodulation market during the forecast period. The India has observed fast growth in the neuromodulation market within the past few years and is expected to lead the market in Asia Pacific during the forecast period. Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation
India Neuromodulation Market Revenue and Forecast to 2027 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFIC NEUROMODULATION – MARKET SEGMENTATION
By Technology
- External (Non-Invasive) Neuromodulation
- Respiratory Electrical Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Internal Neuromodulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
- Spinal Cord Stimulation
- Vagus Nerve Stimulation
By Application
- Chronic Pain Management
- Failed Back Syndrome
- Epilepsy
- Tremor
- Incontinence
- Depression
- Dystonia
- Gastroparesis
- Parkinson’s Disease
- Obsessive-Compulsive Disorder
- Migraine
By Country
- Japan
- China
- India
- South Korea
- Australia
By End User
- Hospitals
- Clinics
- Home Healthcare
By Country
- Japan
- China
- India
- South Korea
- Australia
- RoAPAC
Company Profiles
- Abbott
- Boston Scientific Corporation
- Medtronic
- NeuroPace, Inc.
- NeuroSigma, Inc.
- NEVRO CORP.
- Synapse Biomedical Inc.
- Soterix Medical Inc
- Integer Holdings Corporation
- Magstim
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology Neuromodulation, Application, End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia-Pacific Neuromodulation Market – By Technology
1.3.2 Asia-Pacific Neuromodulation Market – By Application
1.3.3 Asia-Pacific Neuromodulation Market – By End User
1.3.4 Asia-Pacific Neuromodulation Market – By Country
2. Neuromodulation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia-Pacific Neuromodulation– Market Landscape
4.1 Overview
4.2 PEST Analysis
Expert Opinions
5. Neuromodulation Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Neurological Disorders
5.1.2 Growing Developments in Neuromodulation Technology
5.2 Market Restraints
5.2.1 High Cost of Neuromodulation Devices
5.3 Market Opportunities
5.3.1 Rising Demand for Neurostimulation Devices to Treat Chronic Pain
5.4 Future Trends
5.4.1 Technological Advancements
5.5 Impact Analysis
6. Neuromodulation Market Analysis – By Technology
6.1 Overview
6.2 Neuromodulation Market Share, by Technology, 2019 and 2027 (%)
6.3 External Neuromodulation
6.3.1 Overview
6.3.2 External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
6.3.3 Respiratory Electrical Stimulation (RES)
6.3.3.1 Overview
6.3.3.2 Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
6.3.4 Transcutaneous Electrical Nerve Stimulation (TENS)
6.3.4.1 Overview
6.3.4.2 Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
6.3.5 Transcranial Magnetic Stimulation (TMS)
6.3.5.1 Overview
6.3.5.2 Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
6.4 Internal Neuromodulation
6.4.1 Overview
6.4.2 Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
6.4.3 Deep Brain Stimulation (DBS)
6.4.3.1 Overview
6.4.3.2 Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
6.4.4 Sacral Nerve Stimulation (DBS)
6.4.4.1 Overview
6.4.4.2 Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
6.4.5 Gastric Electric Stimulation (GES)
6.4.5.1 Overview
6.4.5.2 Gastric Electric Stimulation (GES): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
6.4.6 Spinal Cord Stimulation (SCS)
6.4.6.1 Overview
6.4.6.2 Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
6.4.7 Vagus Nerve Stimulation (VNS)
6.4.7.1 Overview
6.4.7.2 Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
7. Neuromodulation Market Analysis – By Application
7.1 Overview
7.2 Neuromodulation Market Share, by Application, 2019 and 2027 (%)
7.3 Chronic Pain Management
7.3.1 Overview
7.3.2 Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
7.4 Failed Back Syndrome
7.4.1 Overview
7.4.2 Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
7.5 Epilepsy
7.5.1 Overview
7.5.2 Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
7.6 Tremor
7.6.1 Overview
7.6.2 Tremor: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
7.7 Incontinence
7.7.1 Overview
7.7.2 Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Depression
7.8.1 Overview
7.8.2 Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
7.9 Dystonia
7.9.1 Overview
7.9.2 Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
7.10 Gastroparesis
7.10.1 Overview
7.10.2 Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
7.11 Parkinson’s Disease
7.11.1 Overview
7.11.2 Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
7.12 Obsessive-Compulsive Disorder (OCD)
7.12.1 Overview
7.12.2 Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
7.13 Migraine
7.13.1 Overview
7.13.2 Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8. Neuromodulation Market Analysis – By End User
8.1 Overview
8.2 Neuromodulation Market Share, by End User, 2019 and 2027, (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Clinics
8.4.1 Overview
8.4.2 Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Home Healthcare
8.5.1 Overview
8.5.2 Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
9. Neuromodulation Market Analysis and Forecasts To 2027 – Regional Analysis
9.1 Asia Pacific: Neuromodulation Market
9.1.1 Overview
9.1.2 Asia Pacific: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
9.1.3 Asia Pacific: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
9.1.3.1 Asia Pacific: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.3.2 Asia Pacific: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.4 Asia Pacific: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.5 Asia Pacific: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.6 Asia Pacific: Neuromodulation Market, by Country, 2019 & 2027 (%)
9.1.7 China: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 China: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 China: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
9.1.7.2.1 China: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2 China: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.7.3 China: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.7.4 China: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.8 Japan: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Japan: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Japan: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
9.1.8.2.1 Japan: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2 Japan: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.8.3 Japan: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.8.4 Japan: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.9 India: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.1 India: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.2 India: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
9.1.9.2.1 India: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.9.2.2 India: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.9.3 India: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.9.4 India: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.10 South Korea: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.1 South Korea: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.2 South Korea: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
9.1.10.2.1 South Korea: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.10.2.2 South Korea: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.10.3 South Korea: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.10.4 South Korea: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.11 Australia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
9.1.11.1 Australia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
9.1.11.2 Australia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
9.1.11.2.1 Australia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.11.2.2 Australia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.11.3 Australia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.11.4 Australia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10. Impact of COVID-19 Pandemic on Asia Pacific Neuromodulation Market
10.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 Abbott
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Boston Scientific Corporation
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Medtronic
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 NeuroPace, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 NeuroSigma, Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Nevro Corp.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Synapse Biomedical Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Soterix Medical Inc
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Integer Holdings Corporation
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Magstim
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 3. Asia Pacific: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 4. Asia Pacific: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. Asia Pacific: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. China: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 7. China: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. China: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 9. China: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 10. China: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. Japan: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 12. Japan: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 13. Japan: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Japan: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. Japan: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. India: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 17. India: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 18. India: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. India: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 20. India: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 21. South Korea: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 22. South Korea: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 23. South Korea: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 24. South Korea: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. South Korea: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 26. Australia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 27. Australia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 28. Australia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 29. Australia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 30. Australia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 31. Glossary of Terms, Neuromodulation Market
LIST OF FIGURES
Figure 1. Neuromodulation Market Segmentation
Figure 2. Asia-Pacific Neuromodulation Market – By Country
Figure 3. Asia-Pacific Neuromodulation Market Overview
Figure 4. Internal Neuromodulation Segment Held Largest Share of Product Type Segment in Neuromodulation Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Asia-Pacific Neuromodulation Market- Leading Country Markets (US$ Million)
Figure 7. Asia Pacific PEST Analysis
Figure 8. Neuromodulation Market Impact Analysis of Drivers and Restraint
Figure 9. Neuromodulation Market Share, by Technology, 2019 and 2027 (%)
Figure 10. External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 11. Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 12. Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 13. Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 14. Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 15. Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 16. Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 17. Gastric Electric Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 18. Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 19. Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 20. Neuromodulation Market Share, by Application, 2019 and 2027 (%)
Figure 21. Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 22. Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 23. Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 24. Tremor: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Neuromodulation Market Share, by End User, 2019 and 2027 (%)
Figure 33. Hospitals Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 34. Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 35. Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 36. Asia Pacific: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)
Figure 37. Asia Pacific: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)
Figure 38. Asia Pacific: Neuromodulation Market, by Country, 2019 & 2027 (%)
Figure 39. China: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 40. Japan: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 41. India: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 42. South Korea: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. Australia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
The List of Companies - Asia Pacific Neuromodulation Market
- Abbott
- Boston Scientific Corporation
- Medtronic
- NeuroPace, Inc.
- NeuroSigma, Inc.
- NEVRO CORP.
- Synapse Biomedical Inc.
- Soterix Medical Inc
- Integer Holdings Corporation
- Magstim
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Neuromodulation Market
Nov 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Nov 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Nov 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)